Laddar...
Understanding the biology of melanoma and therapeutic implications
From 1976 – 2010, the US FDA approved only two medications for the treatment of metastatic melanoma, dacarbazine and high-dose interleukin 2. Between 2011–13, four agents were approved (ipilimumab, vemurafenib, dabrafenib, trametinib) and other therapies have shown great promise in clinical trials....
Sparad:
| Huvudupphovsmän: | , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
2014
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4116747/ https://ncbi.nlm.nih.gov/pubmed/24880940 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.hoc.2014.02.007 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|